

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuronal action potential propagation (GO:0019227) | 4.08978804 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 3.97810225 |
| 3 | presynaptic membrane assembly (GO:0097105) | 3.89413314 |
| 4 | metanephric mesenchyme development (GO:0072075) | 3.88096805 |
| 5 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.83611386 |
| 6 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.81544148 |
| 7 | gamma-aminobutyric acid transport (GO:0015812) | 3.76307151 |
| 8 | regulation of synaptic vesicle transport (GO:1902803) | 3.63383811 |
| 9 | protein localization to synapse (GO:0035418) | 3.63160596 |
| 10 | kidney mesenchyme development (GO:0072074) | 3.61471299 |
| 11 | neurotransmitter secretion (GO:0007269) | 3.59518283 |
| 12 | synaptic transmission, glutamatergic (GO:0035249) | 3.55763486 |
| 13 | presynaptic membrane organization (GO:0097090) | 3.54639682 |
| 14 | auditory behavior (GO:0031223) | 3.45065329 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.44627304 |
| 16 | layer formation in cerebral cortex (GO:0021819) | 3.44561562 |
| 17 | regulation of male gonad development (GO:2000018) | 3.41451454 |
| 18 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.35311219 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 3.34989952 |
| 20 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.34381665 |
| 21 | positive regulation of male gonad development (GO:2000020) | 3.33950496 |
| 22 | sodium ion export (GO:0071436) | 3.32527123 |
| 23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.29994213 |
| 24 | synaptic vesicle endocytosis (GO:0048488) | 3.21707570 |
| 25 | nucleobase catabolic process (GO:0046113) | 3.21231675 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 3.19512920 |
| 27 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.16469053 |
| 28 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.15429441 |
| 29 | regulation of cardioblast proliferation (GO:0003264) | 3.15429441 |
| 30 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.12698737 |
| 31 | neuronal ion channel clustering (GO:0045161) | 3.09544976 |
| 32 | establishment of mitochondrion localization (GO:0051654) | 3.08966112 |
| 33 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.05713297 |
| 34 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.03257701 |
| 35 | synapse assembly (GO:0007416) | 2.96722877 |
| 36 | glutamate receptor signaling pathway (GO:0007215) | 2.95823525 |
| 37 | C4-dicarboxylate transport (GO:0015740) | 2.94996543 |
| 38 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.94430831 |
| 39 | regulation of neurotransmitter levels (GO:0001505) | 2.93793924 |
| 40 | mesenchymal to epithelial transition (GO:0060231) | 2.92260559 |
| 41 | gonadal mesoderm development (GO:0007506) | 2.92246124 |
| 42 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.90263713 |
| 43 | dendritic spine organization (GO:0097061) | 2.89445014 |
| 44 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.89257821 |
| 45 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.87936440 |
| 46 | neurotransmitter transport (GO:0006836) | 2.84913519 |
| 47 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.79828755 |
| 48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.78711657 |
| 49 | synaptic vesicle maturation (GO:0016188) | 2.78707695 |
| 50 | neurotransmitter uptake (GO:0001504) | 2.76872195 |
| 51 | regulation of neurotransmitter secretion (GO:0046928) | 2.74990058 |
| 52 | positive regulation of mitochondrial fission (GO:0090141) | 2.74229216 |
| 53 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.73636422 |
| 54 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.72398886 |
| 55 | acidic amino acid transport (GO:0015800) | 2.69526646 |
| 56 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.69398330 |
| 57 | response to auditory stimulus (GO:0010996) | 2.68906529 |
| 58 | lymph vessel development (GO:0001945) | 2.68647665 |
| 59 | membrane depolarization during action potential (GO:0086010) | 2.65850175 |
| 60 | mesenchyme morphogenesis (GO:0072132) | 2.64637579 |
| 61 | regulation of axon guidance (GO:1902667) | 2.64327826 |
| 62 | glycosphingolipid biosynthetic process (GO:0006688) | 2.63760207 |
| 63 | glomerulus development (GO:0032835) | 2.63664361 |
| 64 | glutamate secretion (GO:0014047) | 2.62625283 |
| 65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.61005567 |
| 66 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.60332741 |
| 67 | positive regulation of synapse assembly (GO:0051965) | 2.59908421 |
| 68 | nephron epithelium morphogenesis (GO:0072088) | 2.59380532 |
| 69 | nephron tubule morphogenesis (GO:0072078) | 2.59380532 |
| 70 | regulation of neurotransmitter transport (GO:0051588) | 2.58678766 |
| 71 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.58307794 |
| 72 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.58125544 |
| 73 | regulation of cell communication by electrical coupling (GO:0010649) | 2.58119346 |
| 74 | locomotory exploration behavior (GO:0035641) | 2.58087283 |
| 75 | cerebellar granule cell differentiation (GO:0021707) | 2.57275097 |
| 76 | long-term synaptic potentiation (GO:0060291) | 2.57137487 |
| 77 | axonal fasciculation (GO:0007413) | 2.56325230 |
| 78 | transmission of nerve impulse (GO:0019226) | 2.56196718 |
| 79 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.55863152 |
| 80 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.55823444 |
| 81 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.55573318 |
| 82 | axon extension involved in axon guidance (GO:0048846) | 2.55573318 |
| 83 | mechanosensory behavior (GO:0007638) | 2.55017296 |
| 84 | synaptic vesicle transport (GO:0048489) | 2.53528579 |
| 85 | establishment of synaptic vesicle localization (GO:0097480) | 2.53528579 |
| 86 | regulation of synapse structural plasticity (GO:0051823) | 2.52232241 |
| 87 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.52136968 |
| 88 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.51800212 |
| 89 | glial cell proliferation (GO:0014009) | 2.51414481 |
| 90 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.50968115 |
| 91 | embryonic foregut morphogenesis (GO:0048617) | 2.50740575 |
| 92 | endocardial cushion morphogenesis (GO:0003203) | 2.49431145 |
| 93 | sex determination (GO:0007530) | 2.49427774 |
| 94 | response to gravity (GO:0009629) | 2.49056365 |
| 95 | amino acid import (GO:0043090) | 2.48808881 |
| 96 | positive regulation of membrane potential (GO:0045838) | 2.48677146 |
| 97 | cellular sodium ion homeostasis (GO:0006883) | 2.48613393 |
| 98 | neuron recognition (GO:0008038) | 2.48485086 |
| 99 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.48043691 |
| 100 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.47879232 |
| 101 | skeletal muscle organ development (GO:0060538) | 2.47555412 |
| 102 | cell communication involved in cardiac conduction (GO:0086065) | 2.46494217 |
| 103 | cochlea development (GO:0090102) | 2.43997553 |
| 104 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.43966092 |
| 105 | synapse organization (GO:0050808) | 2.43048902 |
| 106 | regulation of vesicle fusion (GO:0031338) | 2.43022116 |
| 107 | negative regulation of cation channel activity (GO:2001258) | 2.42108395 |
| 108 | renal tubule morphogenesis (GO:0061333) | 2.41764898 |
| 109 | establishment of vesicle localization (GO:0051650) | 2.41632300 |
| 110 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.41150270 |
| 111 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.41150270 |
| 112 | positive regulation of axon extension (GO:0045773) | 2.40183345 |
| 113 | negative regulation of appetite (GO:0032099) | 2.39121565 |
| 114 | negative regulation of response to food (GO:0032096) | 2.39121565 |
| 115 | negative regulation of heart rate (GO:0010459) | 2.39052641 |
| 116 | L-glutamate transport (GO:0015813) | 2.38157302 |
| 117 | nephron tubule formation (GO:0072079) | 2.37425534 |
| 118 | regulation of postsynaptic membrane potential (GO:0060078) | 2.37066948 |
| 119 | behavioral response to cocaine (GO:0048148) | 2.36672688 |
| 120 | outer ear morphogenesis (GO:0042473) | 2.36232085 |
| 121 | glomerular basement membrane development (GO:0032836) | 2.35448401 |
| 122 | potassium ion homeostasis (GO:0055075) | 2.35003766 |
| 123 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.34449648 |
| 124 | metanephric epithelium development (GO:0072207) | 2.34435047 |
| 125 | chondrocyte proliferation (GO:0035988) | 2.33971318 |
| 126 | vocalization behavior (GO:0071625) | 2.31884971 |
| 127 | cell communication by electrical coupling (GO:0010644) | 2.31648408 |
| 128 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.31564464 |
| 129 | response to pheromone (GO:0019236) | 2.30041704 |
| 130 | activation of protein kinase A activity (GO:0034199) | 2.29587203 |
| 131 | postsynaptic membrane organization (GO:0001941) | 2.29168323 |
| 132 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.28928893 |
| 133 | innervation (GO:0060384) | 2.28628060 |
| 134 | regulation of heart morphogenesis (GO:2000826) | 2.28501696 |
| 135 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.27862864 |
| 136 | regulation of female gonad development (GO:2000194) | 2.26968415 |
| 137 | positive regulation of mesonephros development (GO:0061213) | 2.26943023 |
| 138 | dendrite morphogenesis (GO:0048813) | 2.25868196 |
| 139 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.25254638 |
| 140 | establishment of nucleus localization (GO:0040023) | 2.25050420 |
| 141 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.24975336 |
| 142 | axon extension (GO:0048675) | 2.24035702 |
| 143 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.23119683 |
| 144 | collecting duct development (GO:0072044) | 2.22534277 |
| 145 | diaphragm development (GO:0060539) | 2.22427454 |
| 146 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.22425652 |
| 147 | regulation of mesonephros development (GO:0061217) | 2.21281030 |
| 148 | synaptic vesicle exocytosis (GO:0016079) | 2.21132028 |
| 149 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.19326657 |
| 150 | dendritic spine morphogenesis (GO:0060997) | 2.18492535 |
| 151 | proximal/distal pattern formation (GO:0009954) | 2.18412094 |
| 152 | positive regulation of vesicle fusion (GO:0031340) | 2.18406847 |
| 153 | regulation of organ formation (GO:0003156) | 2.18007722 |
| 154 | COPI coating of Golgi vesicle (GO:0048205) | 2.17653068 |
| 155 | Golgi transport vesicle coating (GO:0048200) | 2.17653068 |
| 156 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.15912883 |
| 157 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.15879869 |
| 158 | exploration behavior (GO:0035640) | 2.15563225 |
| 159 | limb bud formation (GO:0060174) | 2.15514470 |
| 160 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.14775341 |
| 161 | negative regulation of catenin import into nucleus (GO:0035414) | 2.14635774 |
| 162 | negative regulation of cartilage development (GO:0061037) | 2.14532025 |
| 163 | positive regulation of gastrulation (GO:2000543) | 2.13605581 |
| 164 | cell differentiation involved in metanephros development (GO:0072202) | 2.13490406 |
| 165 | heart valve formation (GO:0003188) | 2.13376758 |
| 166 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.12693552 |
| 167 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.12064019 |
| 168 | neural crest cell development (GO:0014032) | 2.10315386 |
| 169 | branching involved in ureteric bud morphogenesis (GO:0001658) | 2.10298415 |
| 170 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.10050299 |
| 171 | facial nerve structural organization (GO:0021612) | 2.10010240 |
| 172 | membrane repolarization during action potential (GO:0086011) | 2.09333122 |
| 173 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.08451907 |
| 174 | embryonic heart tube development (GO:0035050) | 2.08275069 |
| 175 | exocrine pancreas development (GO:0031017) | 2.07764424 |
| 176 | mating behavior (GO:0007617) | 2.07748832 |
| 177 | gastrulation with mouth forming second (GO:0001702) | 2.07549569 |
| 178 | relaxation of cardiac muscle (GO:0055119) | 2.07417419 |
| 179 | regulation of glomerulus development (GO:0090192) | 2.07024082 |
| 180 | heart valve morphogenesis (GO:0003179) | 2.06070250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.40541273 |
| 2 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.66281710 |
| 3 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.66281710 |
| 4 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.62484648 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.61759723 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.55917916 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.55599224 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.49422108 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47696688 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47452124 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.46156593 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.43727479 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.41350629 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.36438272 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.34195900 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.30584837 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.26877200 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.17882412 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.16395212 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.07886931 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07449734 |
| 22 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.05830434 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95591861 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93452037 |
| 25 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.92594609 |
| 26 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.89089880 |
| 27 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.86455289 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.82345352 |
| 29 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.81246131 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.74254092 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.70934973 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68107929 |
| 33 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.66588363 |
| 34 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.65576835 |
| 35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.63413567 |
| 36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.60865705 |
| 37 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.55817168 |
| 38 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.53207981 |
| 39 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.53060420 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51607086 |
| 41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51601800 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50777396 |
| 43 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.49080306 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48394385 |
| 45 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.47644595 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45887804 |
| 47 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.42251004 |
| 48 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42233268 |
| 49 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.41965116 |
| 50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41859047 |
| 51 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.41393365 |
| 52 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41030858 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.38889302 |
| 54 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.37517432 |
| 55 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.36377218 |
| 56 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.35917325 |
| 57 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34961561 |
| 58 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34208225 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34064537 |
| 60 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.33766594 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33538162 |
| 62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33283340 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33243760 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.32840883 |
| 65 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29824507 |
| 66 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.29265974 |
| 67 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.28488318 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26426538 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26426538 |
| 70 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.24659163 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24087485 |
| 72 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23405320 |
| 73 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.23232815 |
| 74 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22920504 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22796308 |
| 76 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.21180150 |
| 77 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20585107 |
| 78 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.18795439 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17335120 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16654090 |
| 81 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.15052323 |
| 82 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14757502 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14488675 |
| 84 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14427026 |
| 85 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13433102 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12788106 |
| 87 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.12292022 |
| 88 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11172290 |
| 89 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10247150 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10196659 |
| 91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07763114 |
| 92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07334457 |
| 93 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.06933724 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06407942 |
| 95 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.05974650 |
| 96 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05536536 |
| 97 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04088618 |
| 98 | JUN_21703547_ChIP-Seq_K562_Human | 1.03601239 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03001955 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02629785 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02601157 |
| 102 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.02113423 |
| 103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01695010 |
| 104 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99652510 |
| 105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98613906 |
| 106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98311334 |
| 107 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96834314 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95591209 |
| 109 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95531923 |
| 110 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94959931 |
| 111 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.94461565 |
| 112 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94327670 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93980967 |
| 114 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93668371 |
| 115 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93668371 |
| 116 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.93236166 |
| 117 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92599454 |
| 118 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92401228 |
| 119 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91999675 |
| 120 | * AR_19668381_ChIP-Seq_PC3_Human | 0.91395175 |
| 121 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91240737 |
| 122 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.91183001 |
| 123 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90611045 |
| 124 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88735680 |
| 125 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.88538941 |
| 126 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88364521 |
| 127 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87902762 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87604622 |
| 129 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.87437479 |
| 130 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87279202 |
| 131 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87215478 |
| 132 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86471709 |
| 133 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.85672976 |
| 134 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.85605218 |
| 135 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.85601306 |
| 136 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.84305421 |
| 137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84235603 |
| 138 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83788735 |
| 139 | CJUN_26792858_Chip-Seq_BT549_Human | 0.83759040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 3.10624241 |
| 2 | MP0010030_abnormal_orbit_morphology | 2.56951811 |
| 3 | MP0002064_seizures | 2.46220768 |
| 4 | MP0009046_muscle_twitch | 2.43104932 |
| 5 | MP0003122_maternal_imprinting | 2.42500726 |
| 6 | MP0002736_abnormal_nociception_after | 2.42231689 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 2.33821405 |
| 8 | MP0001486_abnormal_startle_reflex | 2.33096961 |
| 9 | MP0002272_abnormal_nervous_system | 2.32478104 |
| 10 | MP0003283_abnormal_digestive_organ | 2.27789805 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.23426567 |
| 12 | MP0000534_abnormal_ureter_morphology | 2.16871796 |
| 13 | MP0004272_abnormal_basement_membrane | 2.15633634 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.15245241 |
| 15 | MP0003942_abnormal_urinary_system | 2.14021539 |
| 16 | MP0002822_catalepsy | 2.13591726 |
| 17 | MP0002102_abnormal_ear_morphology | 1.98345574 |
| 18 | MP0001188_hyperpigmentation | 1.90537539 |
| 19 | MP0000678_abnormal_parathyroid_gland | 1.85516404 |
| 20 | MP0002733_abnormal_thermal_nociception | 1.83046784 |
| 21 | MP0002909_abnormal_adrenal_gland | 1.82066088 |
| 22 | MP0001970_abnormal_pain_threshold | 1.79673909 |
| 23 | MP0003385_abnormal_body_wall | 1.78672774 |
| 24 | MP0009379_abnormal_foot_pigmentation | 1.78387804 |
| 25 | MP0001502_abnormal_circadian_rhythm | 1.76349909 |
| 26 | MP0000537_abnormal_urethra_morphology | 1.76309278 |
| 27 | MP0009250_abnormal_appendicular_skeleto | 1.74919521 |
| 28 | MP0005503_abnormal_tendon_morphology | 1.73791825 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.73520614 |
| 30 | MP0002249_abnormal_larynx_morphology | 1.73343013 |
| 31 | MP0005623_abnormal_meninges_morphology | 1.72194610 |
| 32 | MP0000049_abnormal_middle_ear | 1.69793152 |
| 33 | MP0001529_abnormal_vocalization | 1.69001655 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.63588721 |
| 35 | MP0005248_abnormal_Harderian_gland | 1.56011013 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.50385894 |
| 37 | MP0004885_abnormal_endolymph | 1.50277970 |
| 38 | MP0003329_amyloid_beta_deposits | 1.48512861 |
| 39 | MP0003635_abnormal_synaptic_transmissio | 1.45967869 |
| 40 | MP0001879_abnormal_lymphatic_vessel | 1.45950818 |
| 41 | MP0001905_abnormal_dopamine_level | 1.45659644 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.44016833 |
| 43 | MP0003880_abnormal_central_pattern | 1.42396231 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.40680899 |
| 45 | MP0008569_lethality_at_weaning | 1.39758667 |
| 46 | MP0000778_abnormal_nervous_system | 1.39456107 |
| 47 | MP0003941_abnormal_skin_development | 1.39171362 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.38983527 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.37176170 |
| 50 | MP0004858_abnormal_nervous_system | 1.34728532 |
| 51 | MP0003121_genomic_imprinting | 1.33695773 |
| 52 | MP0002896_abnormal_bone_mineralization | 1.33495400 |
| 53 | MP0000631_abnormal_neuroendocrine_gland | 1.32514476 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.31945911 |
| 55 | MP0004270_analgesia | 1.30764005 |
| 56 | MP0003123_paternal_imprinting | 1.30444702 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.27844981 |
| 58 | MP0002233_abnormal_nose_morphology | 1.27320018 |
| 59 | MP0004215_abnormal_myocardial_fiber | 1.27312725 |
| 60 | MP0002282_abnormal_trachea_morphology | 1.27259412 |
| 61 | MP0005367_renal/urinary_system_phenotyp | 1.25729944 |
| 62 | MP0000516_abnormal_urinary_system | 1.25729944 |
| 63 | MP0002063_abnormal_learning/memory/cond | 1.25448824 |
| 64 | MP0002882_abnormal_neuron_morphology | 1.25435321 |
| 65 | MP0004924_abnormal_behavior | 1.25288112 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.25288112 |
| 67 | MP0001984_abnormal_olfaction | 1.24687415 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.24648038 |
| 69 | MP0002638_abnormal_pupillary_reflex | 1.24291931 |
| 70 | MP0002184_abnormal_innervation | 1.21472158 |
| 71 | MP0003119_abnormal_digestive_system | 1.21362105 |
| 72 | MP0001270_distended_abdomen | 1.20335675 |
| 73 | MP0003755_abnormal_palate_morphology | 1.20094067 |
| 74 | MP0001299_abnormal_eye_distance/ | 1.19566535 |
| 75 | MP0005394_taste/olfaction_phenotype | 1.19364841 |
| 76 | MP0005499_abnormal_olfactory_system | 1.19364841 |
| 77 | MP0002653_abnormal_ependyma_morphology | 1.19121603 |
| 78 | MP0003115_abnormal_respiratory_system | 1.18213944 |
| 79 | MP0000163_abnormal_cartilage_morphology | 1.17273437 |
| 80 | MP0000762_abnormal_tongue_morphology | 1.17226137 |
| 81 | MP0003633_abnormal_nervous_system | 1.14751276 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 1.14726401 |
| 83 | MP0004233_abnormal_muscle_weight | 1.13910391 |
| 84 | MP0005187_abnormal_penis_morphology | 1.13690235 |
| 85 | MP0002066_abnormal_motor_capabilities/c | 1.13576238 |
| 86 | MP0008789_abnormal_olfactory_epithelium | 1.13425902 |
| 87 | MP0002116_abnormal_craniofacial_bone | 1.13231815 |
| 88 | MP0003935_abnormal_craniofacial_develop | 1.13147143 |
| 89 | MP0001346_abnormal_lacrimal_gland | 1.11648903 |
| 90 | MP0002938_white_spotting | 1.11465400 |
| 91 | MP0003787_abnormal_imprinting | 1.11077936 |
| 92 | MP0002734_abnormal_mechanical_nocicepti | 1.09864642 |
| 93 | MP0002932_abnormal_joint_morphology | 1.09330231 |
| 94 | MP0005508_abnormal_skeleton_morphology | 1.07747691 |
| 95 | MP0004142_abnormal_muscle_tone | 1.06176012 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 1.04917198 |
| 97 | MP0000751_myopathy | 1.04814402 |
| 98 | MP0005253_abnormal_eye_physiology | 1.04369846 |
| 99 | MP0008775_abnormal_heart_ventricle | 1.03967390 |
| 100 | MP0008961_abnormal_basal_metabolism | 1.02069669 |
| 101 | MP0003631_nervous_system_phenotype | 1.01500309 |
| 102 | MP0002557_abnormal_social/conspecific_i | 1.01368006 |
| 103 | MP0000566_synostosis | 0.97938029 |
| 104 | MP0001177_atelectasis | 0.97910724 |
| 105 | MP0001963_abnormal_hearing_physiology | 0.97509572 |
| 106 | MP0000955_abnormal_spinal_cord | 0.97174779 |
| 107 | MP0004484_altered_response_of | 0.96830128 |
| 108 | MP0001440_abnormal_grooming_behavior | 0.96179778 |
| 109 | MP0004134_abnormal_chest_morphology | 0.95629756 |
| 110 | MP0004084_abnormal_cardiac_muscle | 0.95476217 |
| 111 | MP0005377_hearing/vestibular/ear_phenot | 0.94937516 |
| 112 | MP0003878_abnormal_ear_physiology | 0.94937516 |
| 113 | MP0004147_increased_porphyrin_level | 0.94152025 |
| 114 | MP0009053_abnormal_anal_canal | 0.93795183 |
| 115 | MP0004133_heterotaxia | 0.93344294 |
| 116 | MP0009384_cardiac_valve_regurgitation | 0.93221957 |
| 117 | MP0002108_abnormal_muscle_morphology | 0.92853957 |
| 118 | MP0006276_abnormal_autonomic_nervous | 0.92639492 |
| 119 | MP0002152_abnormal_brain_morphology | 0.91409640 |
| 120 | MP0008872_abnormal_physiological_respon | 0.91228629 |
| 121 | MP0003937_abnormal_limbs/digits/tail_de | 0.91057619 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.89506044 |
| 123 | MP0001958_emphysema | 0.87302386 |
| 124 | MP0002069_abnormal_eating/drinking_beha | 0.87018747 |
| 125 | MP0002115_abnormal_skeleton_extremities | 0.86812817 |
| 126 | MP0004742_abnormal_vestibular_system | 0.86777490 |
| 127 | MP0006138_congestive_heart_failure | 0.86636530 |
| 128 | MP0002229_neurodegeneration | 0.86529497 |
| 129 | MP0000026_abnormal_inner_ear | 0.85777502 |
| 130 | MP0009745_abnormal_behavioral_response | 0.85499165 |
| 131 | MP0000428_abnormal_craniofacial_morphol | 0.85452233 |
| 132 | MP0002752_abnormal_somatic_nervous | 0.83632733 |
| 133 | MP0003943_abnormal_hepatobiliary_system | 0.83142441 |
| 134 | MP0001485_abnormal_pinna_reflex | 0.82603095 |
| 135 | MP0001968_abnormal_touch/_nociception | 0.82395316 |
| 136 | MP0008995_early_reproductive_senescence | 0.81813438 |
| 137 | MP0002928_abnormal_bile_duct | 0.81568331 |
| 138 | MP0005423_abnormal_somatic_nervous | 0.81335408 |
| 139 | MP0001986_abnormal_taste_sensitivity | 0.81203729 |
| 140 | MP0003632_abnormal_nervous_system | 0.80396605 |
| 141 | MP0003861_abnormal_nervous_system | 0.80236725 |
| 142 | MP0002177_abnormal_outer_ear | 0.79700071 |
| 143 | MP0004085_abnormal_heartbeat | 0.79672117 |
| 144 | MP0000230_abnormal_systemic_arterial | 0.79584535 |
| 145 | MP0003879_abnormal_hair_cell | 0.79380503 |
| 146 | MP0002109_abnormal_limb_morphology | 0.79247739 |
| 147 | MP0002089_abnormal_postnatal_growth/wei | 0.79202704 |
| 148 | MP0002751_abnormal_autonomic_nervous | 0.79061534 |
| 149 | MP0006072_abnormal_retinal_apoptosis | 0.78196166 |
| 150 | MP0010386_abnormal_urinary_bladder | 0.78018888 |
| 151 | MP0003137_abnormal_impulse_conducting | 0.77659465 |
| 152 | MP0004043_abnormal_pH_regulation | 0.75777913 |
| 153 | MP0003634_abnormal_glial_cell | 0.75150154 |
| 154 | MP0003011_delayed_dark_adaptation | 0.72449642 |
| 155 | MP0005535_abnormal_body_temperature | 0.72194943 |
| 156 | MP0002090_abnormal_vision | 0.71666569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.70843613 |
| 2 | Polyphagia (HP:0002591) | 3.93484384 |
| 3 | Febrile seizures (HP:0002373) | 3.72171668 |
| 4 | Action tremor (HP:0002345) | 3.68903677 |
| 5 | Atonic seizures (HP:0010819) | 3.66988377 |
| 6 | Abnormal eating behavior (HP:0100738) | 3.28693858 |
| 7 | Gait imbalance (HP:0002141) | 3.28326886 |
| 8 | Hemiparesis (HP:0001269) | 3.03718989 |
| 9 | Hepatoblastoma (HP:0002884) | 2.91573698 |
| 10 | Neonatal short-limb short stature (HP:0008921) | 2.90809452 |
| 11 | Medial flaring of the eyebrow (HP:0010747) | 2.81974743 |
| 12 | Split foot (HP:0001839) | 2.81259608 |
| 13 | Congenital primary aphakia (HP:0007707) | 2.79875401 |
| 14 | Spastic gait (HP:0002064) | 2.79842651 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 2.78166177 |
| 16 | Epiphyseal dysplasia (HP:0002656) | 2.76595374 |
| 17 | Hyperventilation (HP:0002883) | 2.70233687 |
| 18 | Germ cell neoplasia (HP:0100728) | 2.68061423 |
| 19 | Absent speech (HP:0001344) | 2.67128253 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 2.66431349 |
| 21 | Abnormality of binocular vision (HP:0011514) | 2.65966236 |
| 22 | Diplopia (HP:0000651) | 2.65966236 |
| 23 | Nephrogenic diabetes insipidus (HP:0009806) | 2.60873442 |
| 24 | Failure to thrive in infancy (HP:0001531) | 2.56019566 |
| 25 | Urinary urgency (HP:0000012) | 2.51210161 |
| 26 | Lower limb muscle weakness (HP:0007340) | 2.47805123 |
| 27 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.47402471 |
| 28 | Epileptiform EEG discharges (HP:0011182) | 2.46814942 |
| 29 | Vitreoretinal degeneration (HP:0000655) | 2.45971016 |
| 30 | Drooling (HP:0002307) | 2.43200743 |
| 31 | Dysdiadochokinesis (HP:0002075) | 2.40186018 |
| 32 | EEG with generalized epileptiform discharges (HP:0011198) | 2.38446947 |
| 33 | Hypsarrhythmia (HP:0002521) | 2.38385523 |
| 34 | Aplasia involving bones of the extremities (HP:0009825) | 2.36326656 |
| 35 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.36326656 |
| 36 | Aplasia of the phalanges of the hand (HP:0009802) | 2.36326656 |
| 37 | Bronchomalacia (HP:0002780) | 2.36245336 |
| 38 | Dialeptic seizures (HP:0011146) | 2.36031062 |
| 39 | Abnormal pancreas size (HP:0012094) | 2.35723021 |
| 40 | Abnormality of the corticospinal tract (HP:0002492) | 2.35276852 |
| 41 | Intention tremor (HP:0002080) | 2.34260253 |
| 42 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.32239596 |
| 43 | Specific learning disability (HP:0001328) | 2.31752719 |
| 44 | Hypoplastic ischia (HP:0003175) | 2.30306067 |
| 45 | Genital tract atresia (HP:0001827) | 2.28682981 |
| 46 | Delusions (HP:0000746) | 2.28380369 |
| 47 | Amyotrophic lateral sclerosis (HP:0007354) | 2.20488390 |
| 48 | Abnormality of dentin (HP:0010299) | 2.20243079 |
| 49 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.18684688 |
| 50 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.18684688 |
| 51 | Spastic tetraplegia (HP:0002510) | 2.15099254 |
| 52 | Vaginal atresia (HP:0000148) | 2.14323757 |
| 53 | Broad-based gait (HP:0002136) | 2.12877601 |
| 54 | Excessive salivation (HP:0003781) | 2.12657216 |
| 55 | Absence seizures (HP:0002121) | 2.12065705 |
| 56 | Abnormality of the ischium (HP:0003174) | 2.11092808 |
| 57 | Clonus (HP:0002169) | 2.10196505 |
| 58 | Protrusio acetabuli (HP:0003179) | 2.10080933 |
| 59 | Enlarged penis (HP:0000040) | 2.06980840 |
| 60 | Mutism (HP:0002300) | 2.06748046 |
| 61 | Short tibia (HP:0005736) | 2.06734225 |
| 62 | Retinal dysplasia (HP:0007973) | 2.05452722 |
| 63 | Abnormal sex determination (HP:0012244) | 2.04824608 |
| 64 | Sex reversal (HP:0012245) | 2.04824608 |
| 65 | Truncal ataxia (HP:0002078) | 2.04524589 |
| 66 | Abnormality of the lower motor neuron (HP:0002366) | 2.02950679 |
| 67 | Supranuclear gaze palsy (HP:0000605) | 2.02699060 |
| 68 | Testicular neoplasm (HP:0010788) | 2.02697850 |
| 69 | Lymphangioma (HP:0100764) | 2.02120350 |
| 70 | Status epilepticus (HP:0002133) | 1.98963983 |
| 71 | Renal duplication (HP:0000075) | 1.96751980 |
| 72 | Hypoventilation (HP:0002791) | 1.96581832 |
| 73 | Myokymia (HP:0002411) | 1.94870270 |
| 74 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.94623552 |
| 75 | Poor eye contact (HP:0000817) | 1.90852486 |
| 76 | Exercise-induced muscle cramps (HP:0003710) | 1.90264819 |
| 77 | Exostoses (HP:0100777) | 1.89986070 |
| 78 | Poor suck (HP:0002033) | 1.88667525 |
| 79 | Papillary thyroid carcinoma (HP:0002895) | 1.88478449 |
| 80 | Pancreatic fibrosis (HP:0100732) | 1.87954972 |
| 81 | Abnormality of the pubic bones (HP:0003172) | 1.86373397 |
| 82 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.86239583 |
| 83 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.85322088 |
| 84 | Upper limb muscle weakness (HP:0003484) | 1.83796463 |
| 85 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.83398285 |
| 86 | Abnormality of the aortic arch (HP:0012303) | 1.82618838 |
| 87 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.82400295 |
| 88 | Sleep apnea (HP:0010535) | 1.81564843 |
| 89 | Dysmetria (HP:0001310) | 1.80503231 |
| 90 | Gaze-evoked nystagmus (HP:0000640) | 1.79051262 |
| 91 | Arterial tortuosity (HP:0005116) | 1.78890129 |
| 92 | Cerebral hypomyelination (HP:0006808) | 1.77655546 |
| 93 | Morphological abnormality of the middle ear (HP:0008609) | 1.77587731 |
| 94 | Mixed hearing impairment (HP:0000410) | 1.74673691 |
| 95 | Anxiety (HP:0000739) | 1.74640939 |
| 96 | Myotonia (HP:0002486) | 1.74639475 |
| 97 | Atrophic scars (HP:0001075) | 1.74611768 |
| 98 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.73716432 |
| 99 | Asymmetry of the thorax (HP:0001555) | 1.73549377 |
| 100 | Decreased central vision (HP:0007663) | 1.73395309 |
| 101 | Neurofibrillary tangles (HP:0002185) | 1.72694539 |
| 102 | Occipital encephalocele (HP:0002085) | 1.72529844 |
| 103 | Ulnar claw (HP:0001178) | 1.72348889 |
| 104 | Bicornuate uterus (HP:0000813) | 1.72185735 |
| 105 | Broad foot (HP:0001769) | 1.71209087 |
| 106 | Megalencephaly (HP:0001355) | 1.70860381 |
| 107 | Optic nerve hypoplasia (HP:0000609) | 1.70268238 |
| 108 | Overgrowth (HP:0001548) | 1.70057314 |
| 109 | Agitation (HP:0000713) | 1.69327343 |
| 110 | Akinesia (HP:0002304) | 1.68529682 |
| 111 | Sprengel anomaly (HP:0000912) | 1.68250994 |
| 112 | Shallow orbits (HP:0000586) | 1.67437197 |
| 113 | Spinal rigidity (HP:0003306) | 1.66761174 |
| 114 | Inability to walk (HP:0002540) | 1.66692391 |
| 115 | Postural instability (HP:0002172) | 1.66540304 |
| 116 | Growth hormone excess (HP:0000845) | 1.66011485 |
| 117 | Cutaneous finger syndactyly (HP:0010554) | 1.65579952 |
| 118 | Broad metatarsal (HP:0001783) | 1.64714679 |
| 119 | Bundle branch block (HP:0011710) | 1.64611121 |
| 120 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.64532984 |
| 121 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.64532984 |
| 122 | Hypoplasia of the corpus callosum (HP:0002079) | 1.64527695 |
| 123 | Poor coordination (HP:0002370) | 1.64259726 |
| 124 | Shoulder girdle muscle weakness (HP:0003547) | 1.63561609 |
| 125 | Focal dystonia (HP:0004373) | 1.62999600 |
| 126 | Lower limb asymmetry (HP:0100559) | 1.62997066 |
| 127 | Elfin facies (HP:0004428) | 1.62522714 |
| 128 | Impaired social interactions (HP:0000735) | 1.62381877 |
| 129 | Abnormal social behavior (HP:0012433) | 1.62381877 |
| 130 | Vascular tortuosity (HP:0004948) | 1.61492467 |
| 131 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.61359965 |
| 132 | Mild short stature (HP:0003502) | 1.60929471 |
| 133 | Renal hypoplasia (HP:0000089) | 1.60691782 |
| 134 | Increased circulating renin level (HP:0000848) | 1.60625338 |
| 135 | Flat acetabular roof (HP:0003180) | 1.60298274 |
| 136 | Shawl scrotum (HP:0000049) | 1.59232867 |
| 137 | Depression (HP:0000716) | 1.58012986 |
| 138 | Type II lissencephaly (HP:0007260) | 1.57373413 |
| 139 | Abnormality of the lacrimal duct (HP:0011481) | 1.53666427 |
| 140 | Gonadal dysgenesis (HP:0000133) | 1.53332182 |
| 141 | Focal seizures (HP:0007359) | 1.52528615 |
| 142 | Buphthalmos (HP:0000557) | 1.51202343 |
| 143 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.50372558 |
| 144 | Cutaneous syndactyly (HP:0012725) | 1.50215416 |
| 145 | Renal dysplasia (HP:0000110) | 1.49770780 |
| 146 | Bladder diverticulum (HP:0000015) | 1.47702794 |
| 147 | Accelerated skeletal maturation (HP:0005616) | 1.47022495 |
| 148 | True hermaphroditism (HP:0010459) | 1.46738996 |
| 149 | Epileptic encephalopathy (HP:0200134) | 1.46517913 |
| 150 | Tracheomalacia (HP:0002779) | 1.46435826 |
| 151 | Broad phalanx (HP:0006009) | 1.46400922 |
| 152 | Broad long bones (HP:0005622) | 1.46350936 |
| 153 | Annular pancreas (HP:0001734) | 1.46034658 |
| 154 | Advanced eruption of teeth (HP:0006288) | 1.45918680 |
| 155 | Metaphyseal cupping (HP:0003021) | 1.45700526 |
| 156 | Broad thumb (HP:0011304) | 1.45220501 |
| 157 | Abnormality of the nasolacrimal system (HP:0000614) | 1.44739746 |
| 158 | Congenital glaucoma (HP:0001087) | 1.44548231 |
| 159 | Broad finger (HP:0001500) | 1.44475361 |
| 160 | Limited hip movement (HP:0008800) | 1.44453586 |
| 161 | Osteoarthritis (HP:0002758) | 1.44321512 |
| 162 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.44215447 |
| 163 | Hydroureter (HP:0000072) | 1.43394480 |
| 164 | Limb dystonia (HP:0002451) | 1.42850113 |
| 165 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.42700201 |
| 166 | Irregular epiphyses (HP:0010582) | 1.41916759 |
| 167 | Hand muscle atrophy (HP:0009130) | 1.41865953 |
| 168 | Visual hallucinations (HP:0002367) | 1.41354385 |
| 169 | Omphalocele (HP:0001539) | 1.41321751 |
| 170 | Flat capital femoral epiphysis (HP:0003370) | 1.41002988 |
| 171 | Unilateral renal agenesis (HP:0000122) | 1.40199889 |
| 172 | Absent eyebrow (HP:0002223) | 1.39564007 |
| 173 | Down-sloping shoulders (HP:0200021) | 1.39055618 |
| 174 | Fetal akinesia sequence (HP:0001989) | 1.38896509 |
| 175 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.38768811 |
| 176 | Hypercalciuria (HP:0002150) | 1.38605971 |
| 177 | Genu varum (HP:0002970) | 1.38440616 |
| 178 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.38160842 |
| 179 | Short 4th metacarpal (HP:0010044) | 1.38160842 |
| 180 | Aortic aneurysm (HP:0004942) | 1.38002701 |
| 181 | Ankle clonus (HP:0011448) | 1.36790378 |
| 182 | Prolonged QT interval (HP:0001657) | 1.36644517 |
| 183 | Visceral angiomatosis (HP:0100761) | 1.36023623 |
| 184 | Torticollis (HP:0000473) | 1.36009756 |
| 185 | Broad ribs (HP:0000885) | 1.35888692 |
| 186 | Hip contracture (HP:0003273) | 1.35630919 |
| 187 | Fibular hypoplasia (HP:0003038) | 1.35448852 |
| 188 | Labial hypoplasia (HP:0000066) | 1.35335864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 3.30348031 |
| 2 | MAP4K2 | 2.80846553 |
| 3 | MARK1 | 2.69010677 |
| 4 | ERBB3 | 2.54346017 |
| 5 | PRKD3 | 2.30325573 |
| 6 | NTRK3 | 2.29606847 |
| 7 | EPHB2 | 2.18563927 |
| 8 | DDR2 | 1.92034035 |
| 9 | EPHA4 | 1.89448975 |
| 10 | CSNK1G3 | 1.88393634 |
| 11 | CSNK1G2 | 1.87504112 |
| 12 | FER | 1.84901085 |
| 13 | CSNK1A1L | 1.83162572 |
| 14 | BCKDK | 1.80987282 |
| 15 | LATS2 | 1.78069934 |
| 16 | MINK1 | 1.77946042 |
| 17 | PIM2 | 1.73647730 |
| 18 | MAP3K9 | 1.71601788 |
| 19 | TRIM28 | 1.67728959 |
| 20 | PINK1 | 1.62116757 |
| 21 | KSR1 | 1.61828816 |
| 22 | WNK4 | 1.60508381 |
| 23 | PDGFRA | 1.59368223 |
| 24 | MAPK15 | 1.58097523 |
| 25 | MAP3K4 | 1.56284204 |
| 26 | PAK3 | 1.53013673 |
| 27 | CSNK1G1 | 1.51815071 |
| 28 | MAP3K2 | 1.50946858 |
| 29 | WNK3 | 1.50709168 |
| 30 | TRIB3 | 1.50488951 |
| 31 | DAPK2 | 1.45923875 |
| 32 | INSRR | 1.40081211 |
| 33 | GRK1 | 1.33141897 |
| 34 | GRK5 | 1.30601840 |
| 35 | TGFBR1 | 1.28300858 |
| 36 | LATS1 | 1.26027153 |
| 37 | LMTK2 | 1.23782791 |
| 38 | TYRO3 | 1.20769712 |
| 39 | BMPR1B | 1.19159546 |
| 40 | PTK2B | 1.17394834 |
| 41 | MAPK13 | 1.15009074 |
| 42 | MAP2K2 | 1.13422500 |
| 43 | NTRK1 | 1.12366908 |
| 44 | PTK2 | 1.10715961 |
| 45 | STK38L | 1.10126597 |
| 46 | CAMK2B | 1.09889207 |
| 47 | PHKG1 | 1.09583338 |
| 48 | PHKG2 | 1.09583338 |
| 49 | FRK | 1.09075603 |
| 50 | MAP3K12 | 1.08990990 |
| 51 | RIPK1 | 1.08923150 |
| 52 | MYLK | 1.08240618 |
| 53 | PAK6 | 1.08165242 |
| 54 | MAP2K1 | 1.06141274 |
| 55 | KSR2 | 1.05922412 |
| 56 | SIK3 | 1.05797800 |
| 57 | MAP2K7 | 0.98997257 |
| 58 | SGK494 | 0.98850944 |
| 59 | SGK223 | 0.98850944 |
| 60 | PASK | 0.98446545 |
| 61 | LIMK1 | 0.96697629 |
| 62 | CCNB1 | 0.96411171 |
| 63 | NTRK2 | 0.96332908 |
| 64 | PTK6 | 0.93264761 |
| 65 | PLK2 | 0.93080525 |
| 66 | STK38 | 0.91252647 |
| 67 | CAMKK1 | 0.89687538 |
| 68 | MAP3K3 | 0.89144431 |
| 69 | TESK1 | 0.88585690 |
| 70 | TAOK1 | 0.87808719 |
| 71 | CDK5 | 0.87165350 |
| 72 | CASK | 0.87067762 |
| 73 | CAMK2G | 0.85265193 |
| 74 | SGK2 | 0.84252888 |
| 75 | MAPKAPK3 | 0.84142419 |
| 76 | ARAF | 0.84118972 |
| 77 | OXSR1 | 0.82908547 |
| 78 | RPS6KA2 | 0.79737579 |
| 79 | EPHA2 | 0.79682429 |
| 80 | RET | 0.79377350 |
| 81 | CDK18 | 0.78536990 |
| 82 | PAK4 | 0.78021245 |
| 83 | TNIK | 0.74895153 |
| 84 | UHMK1 | 0.74008958 |
| 85 | AKT3 | 0.73885894 |
| 86 | DYRK1B | 0.73806850 |
| 87 | DYRK2 | 0.72910514 |
| 88 | PKN2 | 0.72428829 |
| 89 | CDK15 | 0.70316546 |
| 90 | PRKG2 | 0.70094852 |
| 91 | CAMK2D | 0.69756478 |
| 92 | ROCK1 | 0.69611645 |
| 93 | PKN1 | 0.68193247 |
| 94 | NEK6 | 0.68101849 |
| 95 | PRKCE | 0.67561267 |
| 96 | BCR | 0.67028689 |
| 97 | DYRK3 | 0.62472049 |
| 98 | DYRK1A | 0.61653971 |
| 99 | CDK11A | 0.58990090 |
| 100 | EPHA3 | 0.58253101 |
| 101 | FGFR1 | 0.57792557 |
| 102 | PRKCG | 0.55665207 |
| 103 | CAMKK2 | 0.55420772 |
| 104 | CDK8 | 0.54455040 |
| 105 | HIPK2 | 0.53883036 |
| 106 | ERBB2 | 0.53401036 |
| 107 | CDK19 | 0.52956616 |
| 108 | CAMK1G | 0.52661230 |
| 109 | STK39 | 0.52144424 |
| 110 | DAPK1 | 0.51794181 |
| 111 | MAP3K5 | 0.49658150 |
| 112 | BRD4 | 0.49243015 |
| 113 | CAMK1 | 0.48809313 |
| 114 | DMPK | 0.48512993 |
| 115 | MAPK7 | 0.47995264 |
| 116 | MARK2 | 0.47486646 |
| 117 | PDK2 | 0.47400340 |
| 118 | MAP2K4 | 0.47239531 |
| 119 | CDK14 | 0.47153866 |
| 120 | CDC42BPA | 0.46107460 |
| 121 | CAMK4 | 0.45885298 |
| 122 | FGFR2 | 0.45877417 |
| 123 | PRKACA | 0.45100052 |
| 124 | PRKCH | 0.44849251 |
| 125 | SGK3 | 0.44288162 |
| 126 | CAMK2A | 0.43812933 |
| 127 | PNCK | 0.43672841 |
| 128 | CDK9 | 0.43235049 |
| 129 | MAPKAPK5 | 0.43116701 |
| 130 | CSNK1A1 | 0.42668904 |
| 131 | WNK1 | 0.42139400 |
| 132 | BMPR2 | 0.41085898 |
| 133 | MAPK9 | 0.41025461 |
| 134 | PAK2 | 0.40966108 |
| 135 | OBSCN | 0.40814420 |
| 136 | TAOK2 | 0.40443190 |
| 137 | ADRBK2 | 0.36961513 |
| 138 | PRKD1 | 0.36792584 |
| 139 | CSNK1D | 0.35529990 |
| 140 | ADRBK1 | 0.35353109 |
| 141 | DAPK3 | 0.35208758 |
| 142 | BMX | 0.33932719 |
| 143 | PRKG1 | 0.32968761 |
| 144 | PRKCZ | 0.32203336 |
| 145 | PRKCA | 0.32198014 |
| 146 | MAP3K11 | 0.31441706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.10455696 |
| 2 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.99805973 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 1.99489235 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 1.92667275 |
| 5 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.91985240 |
| 6 | Insulin secretion_Homo sapiens_hsa04911 | 1.81507597 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.78381828 |
| 8 | Axon guidance_Homo sapiens_hsa04360 | 1.75741909 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.75131312 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.72059398 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.64838730 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.63513414 |
| 13 | Gap junction_Homo sapiens_hsa04540 | 1.60786626 |
| 14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.60346377 |
| 15 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.60206593 |
| 16 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.59474971 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.59444545 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.57554240 |
| 19 | Melanogenesis_Homo sapiens_hsa04916 | 1.56422814 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.55847993 |
| 21 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.54927063 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.54009647 |
| 23 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.53514469 |
| 24 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.53287254 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.50534615 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.48842431 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.47899796 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.46460512 |
| 29 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.46412641 |
| 30 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.40759614 |
| 31 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.38017028 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36212795 |
| 33 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.36055935 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.34385784 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33419336 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.32296432 |
| 37 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.30706761 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30561854 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.30492573 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30077297 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28942328 |
| 42 | Adherens junction_Homo sapiens_hsa04520 | 1.28314269 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 1.26563507 |
| 44 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.25537412 |
| 45 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.24992973 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23875210 |
| 47 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.19717099 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 1.19114248 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 1.18550082 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16587787 |
| 51 | Taste transduction_Homo sapiens_hsa04742 | 1.15644147 |
| 52 | Glioma_Homo sapiens_hsa05214 | 1.15545242 |
| 53 | Tight junction_Homo sapiens_hsa04530 | 1.14656256 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 1.12484738 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11789633 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11133819 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10298501 |
| 58 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09241947 |
| 59 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.08528776 |
| 60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07572020 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06938019 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06787024 |
| 63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.04338026 |
| 64 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.02133059 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00151580 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.98668555 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98449867 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.98245536 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.97171662 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.96916069 |
| 71 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95132026 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92857495 |
| 73 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92059167 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90629789 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90169165 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88953622 |
| 77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.87881766 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87321937 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86893212 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86625495 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.86500003 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.84681896 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84534230 |
| 84 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83993713 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83759364 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82551386 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82470079 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.82084787 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80891672 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80852738 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.79088029 |
| 92 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.78324853 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.78172924 |
| 94 | Melanoma_Homo sapiens_hsa05218 | 0.77712638 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77424902 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76603924 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76531619 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74298240 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.74089827 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73266085 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73223743 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70960703 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70382507 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70232502 |
| 105 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69376107 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69266301 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68932807 |
| 108 | Bile secretion_Homo sapiens_hsa04976 | 0.68746929 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68452598 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67587461 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.66907690 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.66613302 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64916393 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64593449 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64241303 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63228056 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.63151526 |
| 118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62169955 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62157133 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61863704 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61452364 |
| 122 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60202130 |
| 123 | Alcoholism_Homo sapiens_hsa05034 | 0.59797743 |
| 124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56258715 |
| 125 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55675439 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.55392759 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54180012 |
| 128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53951492 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53708428 |
| 130 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53705080 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53386942 |
| 132 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53358084 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52004665 |
| 134 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50276378 |
| 135 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48868725 |
| 136 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48611562 |
| 137 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47094405 |
| 138 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47037582 |
| 139 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45820465 |
| 140 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44117347 |
| 141 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42126536 |
| 142 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41848833 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | 0.41240450 |
| 144 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40642977 |
| 145 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38087858 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.37198778 |
| 147 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36689334 |
| 148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34617410 |
| 149 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34482828 |

